MA
CVS icon

Montag & Associates’s CVS Health CVS Stock Holding History

Montag & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$814K Hold
11,340
– – 0.04% 261
2025
Q4 		$900K Sell
11,340
-12
-0.1% -$946 0.04% 251
2025
Q3 		$856K Buy
11,352
+12
+0.1% +$822 0.04% 257
2025
Q2 		$782K Sell
11,340
-300
-3% -$19.7K 0.04% 263
2025
Q1 		$789K Hold
11,640
– – 0.04% 265
2024
Q4 		$523K Sell
11,640
-2,835
-20% -$159K 0.02% 315
2024
Q3 		$910K Sell
14,475
-1,814
-11% -$106K 0.04% 254
2024
Q2 		$962K Sell
16,289
-8,720
-35% -$545K 0.05% 236
2024
Q1 		$1.99M Sell
25,009
-2,367
-9% -$181K 0.1% 175
2023
Q4 		$2.16M Sell
27,376
-3,386
-11% -$241K 0.12% 155
2023
Q3 		$2.15M Buy
30,762
+194
+0.6% +$13.7K 0.14% 146
2023
Q2 		$2.11M Buy
30,568
+2,704
+10% +$192K 0.13% 149
2023
Q1 		$2.07M Buy
27,864
+1,060
+4% +$88.9K 0.14% 142
2022
Q4 		$2.5M Buy
26,804
+4,696
+21% +$453K 0.17% 122
2022
Q3 		$2.11M Buy
22,108
+65
+0.3% +$6.43K 0.15% 137
2022
Q2 		$2.04M Sell
22,043
-567
-3% -$55.3K 0.13% 146
2022
Q1 		$2.29M Sell
22,610
-100
-0.4% -$10.5K 0.12% 161
2021
Q4 		$2.34M Buy
22,710
+1,304
+6% +$121K 0.12% 160
2021
Q3 		$1.82M Sell
21,406
-196
-0.9% -$16.4K 0.1% 173
2021
Q2 		$1.8M Sell
21,602
-2,263
-9% -$185K 0.1% 178
2021
Q1 		$1.79M Sell
23,865
-2,000
-8% -$146K 0.1% 175
2020
Q4 		$1.77M Sell
25,865
-2,337
-8% -$152K 0.11% 164
2020
Q3 		$1.65M Buy
28,202
+5,250
+23% +$327K 0.13% 148
2020
Q2 		$1.49M Hold
22,952
– – 0.13% 140
2020
Q1 		$1.36M Sell
22,952
-790
-3% -$52.7K 0.14% 136
2019
Q4 		$1.76M Sell
23,742
-3,230
-12% -$227K 0.14% 140
2019
Q3 		$1.7M Hold
26,972
– – 0.15% 129
2019
Q2 		$1.47M Sell
26,972
-8,675
-24% -$467K 0.13% 142
2019
Q1 		$1.92M Sell
35,647
-1,223
-3% -$75.5K 0.18% 119
2018
Q4 		$2.42M Buy
36,870
+958
+3% +$71.5K 0.26% 94
2018
Q3 		$2.83M Hold
35,912
– – 0.25% 97
2018
Q2 		$2.31M Sell
35,912
-1,192
-3% -$78.6K 0.24% 108
2018
Q1 		$2.31M Sell
37,104
-233
-0.6% -$16.7K 0.24% 116
2017
Q4 		$2.71M Sell
37,337
-6,830
-15% -$497K 0.26% 108
2017
Q3 		$3.59M Sell
44,167
-1,675
-4% -$132K 0.39% 77
2017
Q2 		$3.69M Sell
45,842
-15,760
-26% -$1.24M 0.41% 66
2017
Q1 		$4.84M Sell
61,602
-10,278
-14% -$821K 0.54% 52
2016
Q4 		$5.67M Sell
71,880
-875
-1% -$70.8K 0.67% 46
2016
Q3 		$6.47M Sell
72,755
-26,815
-27% -$2.53M 0.82% 31
2016
Q2 		$9.53M Sell
99,570
-5,510
-5% -$549K 1.26% 12
2016
Q1 		$10.9M Buy
105,080
+41,910
+66% +$4.08M 1.53% 12
2015
Q4 		$6.18M Buy
63,170
+875
+1% +$85.7K 0.91% 28
2015
Q3 		$6.01M Buy
62,295
+3,289
+6% +$346K 0.94% 28
2015
Q2 		$6.19M Sell
59,006
-6,225
-10% -$636K 0.9% 32
2015
Q1 		$6.73M Sell
65,231
-1,137
-2% -$115K 0.97% 26
2014
Q4 		$6.39M Buy
66,368
+1,900
+3% +$167K 0.96% 29
2014
Q3 		$5.13M Buy
64,468
+250
+0.4% +$19.7K 0.85% 33
2014
Q2 		$4.84M Sell
64,218
-1,170
-2% -$88.4K 0.79% 38
2014
Q1 		$4.89M Sell
65,388
-2,150
-3% -$152K 0.83% 35
2013
Q4 		$4.83M Hold
67,538
– – 0.83% 37
2013
Q3 		$3.83M Sell
67,538
-844
-1% -$50.3K 0.72% 48
2013
Q2 		$3.91M Buy
+68,382
New +$3.96M 0.8% 45

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Montag & Associates's CVS Position: Q1 2026 in Review

Montag & Associates held its CVS Health (CVS) position steady in Q1 2026 at 11,340 shares worth $814K. The position accounts for 0.04% of the portfolio, ranked #261.

Montag & Associates first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.9M in Q1 2016. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Montag & Associates held 11,340 shares of CVS Health worth $814K as of Q1 2026.
  • Montag & Associates left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up 0.04% of Montag & Associates's portfolio in Q1 2026, its #261 holding.
  • Montag & Associates first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Montag & Associates's CVS Health position peaked at $10.9M in Q1 2016.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.